Skip to content

Author

Ying-Xue Dong

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Immune checkpoint inhibitor-associated arrhythmias: clinical challenges, artificial intelligence-enhanced monitoring, and management strategies

Immune checkpoint inhibitors (ICIs) have revolutionized the therapeutic landscape for a broad spectrum of malignancies, substantially prolonging patient survival. However, the widespread clinical adoption of ICIs is challenged by a diverse array of cardiovascular immune-related adverse events (CV-irAEs). Among these, a...

Yi-Fu Xia, Hao-Yu Dong, Xiang-Zhu Meng et al. · 0 citations
Open access Sep 2026

The CMPK2–mtDNA axis mediates doxorubicin cardiotoxicity: mechanistic links to STAT1 transcription and FAD-mediated inhibition

CMPK2 is established as a key mediator of doxorubicin cardiotoxicity, integrating STAT1-mediated transcriptional regulation with mtDNA-dependent NLRP3 inflammasome activation into a unified pathological axis, addressing a major challenge in cardio-oncology.

Zhen-Yu Feng, Li Lin, Yi-Jin Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.